Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
Targacept is a clinical-stage biopharmaceutical company that discovers and develops NNR Therapeutics, a new class of drugs for the treatment of central nervous system diseases and disorders. Targacept’s product candidates selectively modulate neuronal nicotinic receptors that serve as key regulators of the nervous system activity to promote therapeutic effects and limit adverse side effects. Targacept has product candidates in development for Alzheimer’s disease and cognitive deficits in schizophrenia, pain and depression, and multiple preclinical programs. Targacept is located in Winston-Salem, North Carolina. NNR Therapeutics is a trademark of Targacept, Inc. ( www.targacept.com )
Targacept , Inc.
200 East First Street Suite 300
Winston-Salem, North Carolina 27101
USA
Tel: (336) 480-2100
Fax: (336) 480-2107